146 related articles for article (PubMed ID: 11042666)
21. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S
Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients.
Meijer E; Cornelissen JJ
Curr Opin Hematol; 2008 Nov; 15(6):576-85. PubMed ID: 18832928
[TBL] [Abstract][Full Text] [Related]
23. [Adoptive transfer of Epstein-Barr virus-specific T-lymphocytes in chronic active Epstein-Barr infection].
Babel N; Hammer MH; Reinke P
Dtsch Med Wochenschr; 2003 Mar; 128(11):548-50. PubMed ID: 12635027
[TBL] [Abstract][Full Text] [Related]
24. Chronic active Epstein-Barr virus infection with mosquito allergy successfully treated with reduced-intensity unrelated allogeneic bone marrow transplantation in a boy.
Matsunaga T; Kurosawa H; Okuya M; Nakajima D; Hagisawa S; Sato Y; Fukushima K; Sugita K; Arisaka O
Pediatr Transplant; 2009 Mar; 13(2):231-4. PubMed ID: 18627511
[TBL] [Abstract][Full Text] [Related]
25. Active Epstein-Barr virus infection after allogeneic stem cell transplantation: re-infection or reactivation?
Meijer E; Spijkers S; Moschatsis S; Boland GJ; Thijsen SF; van Loon AM; Verdonck LF
Transpl Infect Dis; 2005 Mar; 7(1):4-10. PubMed ID: 15984942
[TBL] [Abstract][Full Text] [Related]
26. Reduced-intensity SCT for chronic active EBV infection: excellent outcomes should trigger future investigations on how EBV-positive recipient cells are eradicated.
Gottschalk S
Bone Marrow Transplant; 2011 Jan; 46(1):18-9. PubMed ID: 20956953
[No Abstract] [Full Text] [Related]
27. Successful report of reduced-intensity stem cell transplantation from unrelated umbilical cord blood in a girl with chronic active Epstein-Barr virus infection.
Iguchi A; Kobayashi R; Sato TZ; Nakajima M; Kaneda M; Ariga T
J Pediatr Hematol Oncol; 2006 Apr; 28(4):254-6. PubMed ID: 16679925
[TBL] [Abstract][Full Text] [Related]
28. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
[TBL] [Abstract][Full Text] [Related]
29. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
Meerbach A; Wutzler P; Häfer R; Zintl F; Gruhn B
J Med Virol; 2008 Mar; 80(3):441-54. PubMed ID: 18205222
[TBL] [Abstract][Full Text] [Related]
30. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
[TBL] [Abstract][Full Text] [Related]
31. [Epstein-Barr virus (EBV) infections in patients treated with allogenic hematopoietic cells transplantation (allo-HCT)].
Zawilińska B; Piatkowska-Jakubas B; Kopeć J; Daszkiewicz E; Kleszcz E; Szostek S; Mensah-Glanowska P; Hawrylecka D; Skotnicki A
Przegl Epidemiol; 2006; 60(1):87-92. PubMed ID: 16758744
[TBL] [Abstract][Full Text] [Related]
32. T cell therapy of Epstein-Barr virus and adenovirus infections after hemopoietic stem cell transplant.
Comoli P; Basso S; Labirio M; Baldanti F; Maccario R; Locatelli F
Blood Cells Mol Dis; 2008; 40(1):68-70. PubMed ID: 17904879
[TBL] [Abstract][Full Text] [Related]
33. [Chronic active Epstein-Barr virus infection treated with reduced intensity stem cell transplantation].
Sakata N; Sato E; Sawada A; Yasui M; Inoue M; Kawa K
Rinsho Ketsueki; 2004 May; 45(5):393-6. PubMed ID: 15199749
[TBL] [Abstract][Full Text] [Related]
34. Persistently high Epstein-Barr virus (EBV) loads in peripheral blood lymphocytes from patients with chronic active EBV infection.
Maeda A; Wakiguchi H; Yokoyama W; Hisakawa H; Tomoda T; Kurashige T
J Infect Dis; 1999 Apr; 179(4):1012-5. PubMed ID: 10068600
[TBL] [Abstract][Full Text] [Related]
35. [Significance of detecting the EBV-DNA level in peripheral blood mononuclear cells and the EBV-infected cell type in patients with chronic active EBV infection].
Xing Y; Song HM; Wu XY; Wang W; Wei M
Zhonghua Er Ke Za Zhi; 2011 Jul; 49(7):495-500. PubMed ID: 22088177
[TBL] [Abstract][Full Text] [Related]
36. Clonal expansion of multiphenotypic Epstein-Barr virus-infected lymphocytes in chronic active Epstein-Barr virus infection.
Endo R; Yoshioka M; Ebihara T; Ishiguro N; Kikuta H; Kobayashi K
Med Hypotheses; 2004; 63(4):582-7. PubMed ID: 15325000
[TBL] [Abstract][Full Text] [Related]
37. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
[TBL] [Abstract][Full Text] [Related]
38. Chronic active Epstein-Barr virus infection in an adult with no detectable immune deficiency.
de Boer M; Mol MJ; Bogman MJ; Galama JM; Raymakers RA
Neth J Med; 2003 Nov; 61(11):376-82. PubMed ID: 14768722
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease.
Burns DM; Crawford DH
Blood Rev; 2004 Sep; 18(3):193-209. PubMed ID: 15183903
[TBL] [Abstract][Full Text] [Related]
40. Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation.
Okamura T; Hatsukawa Y; Arai H; Inoue M; Kawa K
Lancet; 2000 Jul; 356(9225):223-4. PubMed ID: 10963205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
